Veru Sets 1-for-10 Reverse Stock Split
(RTTNews) - Veru Inc. (VERU), a late clinical stage biopharmaceutical company, Wednesday announced a 1-for-10 reverse stock split, effective August 8.
This action is primarily to regain compliance with the Nasdaq $1.00 minimum bid price requirement.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.